Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01521364|
Recruitment Status : Completed
First Posted : January 30, 2012
Results First Posted : July 1, 2013
Last Update Posted : July 1, 2013
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Extensively Drug-resistant Tuberculosis
Drug: Addition of different doses of clarithromycin.
The study was performed at the Tuberculosis Centre Beatrixoord (University of Groningen, University Medical Center Groningen, Haren, The Netherlands).
Dates of recruitment: from december 2011 to november 2012.
|Pre-assignment Details||Not applicatble.|